Table 2.

Age/sex case fatality rates (CFRs) and infection fatality rates (IFRs) in baseline populations, in patients with cancer and in patients with cancer receiving chemotherapy

Age/sex group	CFR by age and sex	IFR by age and sex	IFR with cancer	IFR with cancer and chemotherapy
0–19 Male	0.01%	0.00%	0.01%	0.01%
0–19 Female	0.00%	0.00%	0.00%	0.01%
20–29 Male	0.04%	0.02%	0.05%	0.09%
20–29 Female	0.02%	0.01%	0.03%	0.05%
30–39 Male	0.07%	0.03%	0.07%	0.15%
30–39 Female	0.04%	0.02%	0.04%	0.09%
40–49 Male	0.17%	0.08%	0.18%	0.36%
40–49 Female	0.09%	0.05%	0.10%	0.20%
50–59 Male	0.66%	0.32%	0.70%	1.41%
50–59 Female	0.37%	0.18%	0.40%	0.81%
60–69 Male	2.39%	1.14%	2.51%	4.97%
60–69 Female	1.37%	0.65%	1.44%	2.89%
70–79 Male	7.57%	3.60%	7.69%	14.51%
70–79 Female	4.42%	2.10%	4.57%	8.89%
80–89 Male	18.67%	8.89%	17.87%	30.70%
80–89 Female	11.48%	5.47%	11.43%	20.80%
90+ Male	32.42%	15.44%	28.93%	45.32%
90+ Female	21.32%	10.15%	20.13%	33.91%
Total Male	2.45%	1.17%	2.57%	5.09%
Total Female	1.40%	0.67%	1.47%	2.96%